British Journal of Rheumatology 1993: Vol 32 Index

41 Pages·1993·15.1 MB·English

GENERAL INDEX—VOLUME 32
(Al and A2 = Abstracts Supplements 1 and 2; $1, $2, S3 and S4 = Supplements 1, 2, 3 and 4;
E = Editorial; L = Letter to the Editor)
AAKEsson A See Scheja A Agammaglobulinaemia, juvenile ankylosing spondylitis in X-linked, (L) 938
AARDEN LA See van den Brink MJG Age, health perception and rheumatoid arthritis, (A2) 58
Assot SE, Harvey SL, Stevens CR, BLake DR. Increased expression of Agranulocytosis, drug-induced, granulocyte colony stimulating factor in, (L)
ELAM.-1 by synovial microvascular endothelial cells is not associated with 1029
increased leucocyte adhesion in vitro, (A1) 20 AcutLerA I See Yélamos J
Assor SE, Stevens CR, Blake DR. Immunomagnetic endothelial cell iso- AHMAD A, AFGHAN S, RAYKUNDALIA C, GARBE T, SITUNAYAKE RD, CHEUNG NT,
lation, (A1) 19 Carty D. Detection of mycobacterial related antigen in serum immune
Assot SE See also Harley SL; Stevens CR complexes of rheumatoid arthritis patients using antigen capture Enzyme
Assott CA See Helliwell PS Linked Immunosorbent Assay (ELISA), (A1) 34
Assou CC See Ollivaud L AxumaDi K See Ebringer A
ABC of the diabetic hand — advanced glycosylation end products, browning AHMED T See D’Cruz D
and collagen, (E) 859 Ano H See Peltonen R
ABDUL-AHAD AK See Jawad ASM AHSAN Q See Hussein K
Abnormal faecal flora of Clostridium perfringens in rheumatoid arthritis and Alcarb! G, BENSO L, VIGNOLO M, TERRAGNA A, VERRINA E, Corpone G, Coppo
other diseases, (L) 939 R, SERNIA O, SARDELLA ML, DI Barrista E, Nasecut A, MiLant S. Dose-
Abnormal fibrinolysis in chronic low back pain, (L) 764, (L) 853 dependent effects of deflazacort and prednisone on growth and skeletal
Abnormal thermoregulatory responses in patients with reflex sympathetic dys- maturation, (S2) 39
trophy, (A1) 78 AICHER WK See Stransky G
ABUZAKOUK M, FEeIGHERY C, BERGIN C, Casey E, Weir D, O’Farre.ty C. AlpINnis V See Manoussakis MN
Increased intestinal gammadelta T cells associated with circulating dietary Air in the oesophagus: a sign of oesophageal involvement in systemic sclerosis,
protein antibodies in rheumatoid arthritis, (A1) 30 (A1) 86
ABUZAKOUK M, FEIGHERY C, Casey E, Weir D, O’FarreLLy C. Increased MHC Airways obstruction in non-smoking rheumatoid arthritis patients, (A2) 3
class II expression on duodenal enterocytes and intraepithelial lympho- Aizawa H See Miyagawa Y
cytes from rheumatoid arthritis patients off NSAID treatment, (A1) 29 Aki M, Bourne JT. Severe digital vasculitis as a manifestation of occult car-
Acasuso Diaz M, CoLiantes Estévez E, SANCHEZ Guuo P. Joint hyperlaxity cinoma, (A1) 145
and musculoligamentous lesions: study of a population of homogeneous AKIL M See also Foley-Nolan D
age, sex and physical exertion, 120 A.-HILtawi AH See Chakravarty K
Achillodynia, use of ultrasonography in the diagnosis and treatment associated Atavi A, Jones MG, Bonp A, Hay FC, Axrorp JS. Glycosylation abnormal-
with inflammatory joint disease, (A1) 100 ities in an experimental model of arthritis, (A1) 30
Acquired vitamin D resistant hypophosphataemic osteomalacia — report of 3 ALBorINoO D See Pancaldi P
cases, (A2) 61 A oricu § See Lloyd J
Activation of self hsp60-specific T cells in inflammation does not depend on ALEXANDER HD See Bell AL
cross-reactivity with mycobacterial hsp65, (A1) 14 ALExopPOoUuLou I See Ludwin D
Acute arthropathy following stroke — a hospital study, (A2) 55 Algodystrophy
Acute hot joint changes in cortical and trabecular bone, 46
in general practice, (A2) 56 of lower limb, comparison of guanethidine blocks and epidural analgesia,
process and outcome audit, (A1) 156 (A2) 53
Acute-phase proteins Aut-GomsBeE A, Crort P. Osteoarthritis and acetabular dysplasia in women,
effects of disease-modifying anti-rheumatic drugs, steroids and non-ste- (Al) 141
roidal anti-inflammatory drugs in rheumatoid arthritis, (S3) 14 Alkaline phosphatase, increased total in rheumatoid arthritis: is it due to bone
reduction with tenidap sodium, a cytokine-modulating anti- rheumatic or other isoenzymes, (A1) 44
drug, (S3) 19 Allele
role in rheumatoid arthritis, (S3) 1 of tumour necrosis factor (NF) alpha is associated with systemic lupus
Acute-phase response in relation to radiographic progression in early rheu- erythematosus and autc antibody production, (A1) 161
matoid arthritis: a prospective study during the first three years of the of type II collagen frequency in collagen antibody-positive rheumatoid
disease, (S3) 9 arthritis patients, (L) 1117
Adamantiades-Beh¢et’s disease, systemic sclerosis occurring in patient with, ALLEN L See Barnsley L
160 ALLEN ME, Mac eop A, Younc SP, Bacon PA. IntracelluTl acerl l signalling in
Apams JE See Jones PBB rheumatoid arthritis, (A1) 28
Additive effect of combined naproxen and paracetamol in rheumatoid arthri- ALLEN R See LoftusJ
tis, 1077 ALLMAN ST. Europe and the 1990s, implications of 1992 on health care in
Apesaso AO. Antineutrophil cytoplasmic antibody titres in patients with Europe, (S4) 31
recent infection, (L) 941 ALonso F See Castro-Guardiola A
ApeBaJo AO, HAZLEMAN BL. Negative association between HIV2 and rheu- ALONSO PULPON L See Barbadillo C
matoid arthritis, (A1) 36 ALonso-Ruiz A, Garcia-Lopez F, CALABozo M, Perez-Ruiz F, MuNoz M.
ApeBaJo AO, Jones M, Bonp A, HAZLEMAN BL, Hay F. Glycosylation Predictors of toxicity induced by methotrexate therapy in patients with
abnormalities in association with rheumatoid arthritis and tropical infec- rheumatoid arthritis, (A1) 52
tions, (A2) 11 A onso-Ruiz A See also Perez-Ruiz F
Apesaso AO, WiLLIAMsS DG, HAZLEMAN BL, VENaBLEs PJ. Anti-RANA anti- Alternative therapies, do patients with rheumatological diseases consider
bodies in an African RA population, (A1) 3 them, (A2) 60
Avesaso AO, WiLLiaMs DG, WiLuiaMs D, HAZLEMAN BL, Maini RN. Levels of Aluminium-related bone disease presenting with calcaneal stress fractures, (L)
IgG antibody to the mycobacterial 65 kilodalton heat shock protein in sera 260
of patients with rheumatoid arthritis, (A1) 14 ALVAREZ R See Mufioz-Fernandez S
Apesajo AO See also Vecchio P AuzaGa X See Castro-Guardiola A
Adhesion molecules Aminopropylidene bisphosphonate in patients with refractory Paget’s disease,
detection in rheumatoid synovial fluid, (A1) 22 (L) 767
intercellular in normal synovium, 302 Amlopidine in the treatment of Raynaud’s phenomenon, (L) 524
ApsayE J See Choy EHS Amor B See Calin A
Adjuvant arthritis, oil vehicles have a similar protective effect against as heat Amos N See Camilleri JP; Teh LS; Williams AS
shock proteins, (A1) 33 Amos R See Nisar M
Apu D, Berisa F, Howie AJ, Emery P, Bacon PA, McConkey B, McGOoniGLE Amyloid
RJS, Micuaets J, Popert AJ. Glomerulonephritis in rheumatoid arthritis, arthritis associated with IgM kappa lymphoplasmacytoid lymphoma, 1004
1008 treatment in rheumatic disease — (1) colchicine is of limited use; (2) the
Apou D See also Luqmani RA; Roussou E case for more immunosuppression, (A2) 22
Adult-onset Still’s disease, osseous tuberculosis traced by magnetic resonance Anaemia of rheumatoid arthritis, relationship of haemogiobin to serum eryth-
imaging, (L) 522 ropoietin concentrations in: effect of oral prednisolone, 204
Advances in immunotherapy of rheumatoid arthritis: clinical and immunolog- Analysis
ical findings following treatment with anti-CD4 antibodies, (S4) 39 of the associations of HLA-DR4 with subgroups of rheumatoid arthritis: is
AFGHAN S See Ahmad A the association with joint disease or extra- articular features, (A1) 113
Agalactosyl IgG [GAL(0)] — an analysis of its clinical utility in the long term of peripheral blood lymphocyte adherence to endothelial cell monolayers
follow up of adult onset rheumatoid arthritis, (A1) 31 in rheumatoid arthritis, (Al) 24
GENERAL INDEX
of two IgG anti-DNA antibody idiotypes in SLE — association with mus- Anti-rheumatoid drugs
culoskeletal disease, (A1) 9 disease modifying, monitoring of patients, (L) 87
ANAND P See Jolliffe VA optimizing the assessment of disease activity during treatment, 467
ANCA-associated diseases in 1992, 150 Anti-RNP antibodies, long term follow-up of patients, (A1) 84
ANDERSON JC See Jones PBB Anti-TNF, anti-CD4 treatment of establishes collagen-induced arthritis pre-
ANDERTON S, VAN Der ZeE R, Goopacre JA. Activation of self hsp60-specific vents joint erosion when combined, (A2) 21
T cells in inflammation does not depend on cross- reactivity with mycobac- Anti-topoisomerase-1 antibodies are found in the majority of males with silica-
terial hsp65, (A1) 14 associated systemic sclerosis and all inhibit topoisomerase-1 function,
ANDREASEN A See Drewes AM (Al) 92
Anpreu JL, Moreno I, BarBapILLo C, MAZZUCCHELLI R, MuLERO J, Mar- Antibodies
rinEz-A C. T cell vaccination prevents autoimmune disease in MRL Ipr to HLA enhance sCD23 production by EBV-transformed cell lines, (A1) 3
mice, (A1) 28 to oxidised DNA in SLE and RA, (A2) 29
Anpreu JL See also Barbadillo C; Mulero J to type II collagen in carly rheumatoid arthritis, 333
ANDREW EM See Mageed RA Anticardiolipin, anticentromere and antitopoisomerase antibodies in patients
ANprEw SM See Snowden N with systemic sclerosis and severe digital ischaemia, (A2) 34
Anprews D See Moots RJ Anticentromere antibodies, clinical features, diagnoses and evolution, 297
Angioendotheliomatosis, malignant (intravascular lymphomatosis), an Anticentromere positive patients, characterisation of a 26/23 kD polypeptide
unusual cutaneous lymphoma in rheumatoid arthritis, 932 doublet, (A1) 11
Angiotensin binding sites in human synovium, (A1) 37 Antineutrophil cytoplasmic antibodies
Ankylosing spondylitis IgG from P-ANCA positive patients with small vessel vasculitis will acti-
comparison of three different physiotherapy regimes, (A1) 103 vate neutrophils and induce an increase in endothelial permeability,
controlled prospective study of the sex ratios among relatives of patients (Al) 17
with HLA-related diseases, (A1) 63 stimuli which provoke production, (A1) 16
correlation between a new metrology score and radiology, (A1) 65 titres in patients with recent infection, (L) 84, (L) 941
course and the effects of sulphasalazine over 3 years, 729
Antiovarian antibodies in systemic lupus erythematosus, (A1) 12
defining spinal mobility, a new metrology score, (A1) 65 Antiperinuclear factor (APF) is not associated with the inflammatory activity
Dutch functional index, (A1) 64 of rheumatoid arthritis, (A1) 13
effect of exercise — a preliminary study, 498 Antiphospholipid antibodies, psychiatric disorders in patients with systemic
family history in: relationship between the sex of the index case and the lupus erythematosus, (L) 646
numbers and sex of diseased relatives, (A2) 23 Antiphospholipid syndrome
interleukin-6, acute phase reactants and clinical status, (A1) 165 B, glycoprotein-1 levels in SLE, antiphospholipid syndrome and hyper-
intestinal permeability to sugars, (A1) 63 lipidaemia: the relationship between antigen and antiphospholipid
is bone density affected by associated conditions or the patterns of joint cofactor function, (A2) 31
involvement, (A1) 64 stimulation of von Willebrand factor antigen release by immunoglobulin
is there a difference between male and female bone density and vertebral from thrombosis prone patients, 123
fracture rates, (A1) 131
Antiribosomal P protein antibodies in different populations of patients with
new approach to defining disease status: the Bath ankylosing spondylitis
systemic lupus erythematosus, 663
disease activity index (BASDAI), (A2) 23 Apoptosis or programmed cell death of human lymphocytes caused by anti-
no additional role for the MHC class II encoded components of the HLA
class I pathway of antigen presentation (LMP2, TAP1 & 2) in the CD4 monoclonal antibody, (A1) 90
Appendicular skeleton, MRI, (E) 945
aetiology, (A2) 25
Approaches to the management of rheumatoid arthritis: rationale for early
patients’ perceptions of disease modulation by diet in inflammatory (rheu-
matoid arthritis/ankylosing spondylitis) and degenerative arthro- combination therapy, (S1) 24
pathies, (A2) 24 AraGON A, CEerOn A. Arthritis in Mediterranean spotted fever. An immune
the relationship between self-assessment instruments, metrology and complex mediated synovitis, 642
radiology, (A1) 66 ARELLANO F, Krupp P. Malignancies in rheumatoid arthritis patients treated
in women: disease onset and course — relationship to childbearing status, with cyclosporin A, (S1) 72
(Al) 66 Arias M See Calvo-Alén J
Annexins I, II, IV and VI, localisation in the rheumatoid synovium, (A1) 38 ARMADANS LI See Castro-Guardiola A
ANSELL B, Beeson M, Hatt P, Beprorp P, Woo P. HLA and juvenile psoriatic Armas J See Jones SM
arthritis, 836 ARMSTRONG RD See Smith RW
ANSELL BM See Davies UM; LoftusJ ARNAL C See Marsal S
Anterior mediastinal fibrosis with superior vena caval obstruction complicat- ARNALICH F See De Miguel E; Hernanz A
ing the synovitis—acne—pustulosis—-hyperostosis— osteomyelitis syndrome, ARNOLD MM. Case of reactive arthritis following exposure to industrial gases
408 and oils, (L) 438
ANTHONY M See Foley-Nolan D ARNOLD MM. Upper gastrointestinal complaints and complications in chronic
Anti-CD4 antibodies, advances in immunotherapy of rheumatoid arthritis: rheumatic patients in comparison with other chronic diseases, (L) 437
clinical and immunological findings following treatment, (S4) 39 ARNOLD MM, McKenna F. Non-steroidal anti-inflammatory drugs, associated
Anti-CD4 monoclonal antibody gastroduodenal damage — do duodenal ulcers cause more symptoms and
apoptosis or programmed cell death of human lymphocytes, (A1) 90 complications, (A1) 57
daily treatment with chimaeric: clinical and immunological response in Arntz OJ See van Beuningen HM
peripheral blood and synovial fluid, (A1) 55 Arora A, CHua A, KEELING PWN, Casey EB. Fibromyalgia and functional
Anti-CD4 treatment of established collagen-induced arthritis prevents joint bowel disorder: common pathogenic process, (A1) 71
erosion when combined with anti-TNF, (A2) 21 Arora RC, MAxweL- S, THorPe G, MARwAH S, BAREFORD D, SITUNAYAKE RD.
Anti-centromere antibodies, incidence in connective tissue diseases using Loosely bound iron and synovial fluid chain breaking antioxidant status in
cloned autoantigen CENP-B, (A1) 11 rheumatoid and osteoarthritis, (A1) 161
Anti-centromere autoantibody detection using a newly developed enzyme Arrest of radiological progression in rheumatoid arthritis during remission,
linked immunosorbent assay, (A2) 34 (A2)7
Anti-cytokines and cytokines, (S1) 15 Arthritic knees, tenascin is increased in cartilage and synovium, 780
Anti-DNA antibodies Arthritis
human IgG anti-DNA antibody precomplexed with DNA inducement in and the effect of exercise on the plasminogen activator system in serum
BALB/C mice, (A1) 10 and synovial fluid, (A1) 157
in the primary antiphospholipid syndrome, 362, (L) 1028 chronic, health status of adults with since childhood: a collaborative study
Anti-gag antibodies, heterogeneity of antigens reactive with in autoimmune between the Republic of Ireland and Northern Ireland, (A2) 59
disease, (A1) 5 development in the pig, effect of dietary fish powder on intestinal flora,
Anti-Jo-1 antibody, significance in D-penicillamine and polymyositis, 1109 1049
Anti-myeloperoxidase antibodies in sera from patients with lung fibrosis asso- early, genetic factors influencing the outcome - the role of sulphoxidation
ciated with rheumatoid arthritis, (A2) 64 status, (L) 170
Anti-P antibodies are associated with psychiatric and focal cerebral disorders increasing awareness — the public’s response, 623
in patients with systemic lupus erythematosus, 287 interaction with neuroendocrine system, (E) 441
Anti-ro(SSA) antibody detection in autoimmune disease: comparison of five in London hospitals from 1720 to 1837, (A1) 147
methods, 449 in Mediterranean spoiied fever. An immune complex mediated synovitis,
Anti-RANA antibodies in an African RA population, (A1) 3 642
Anti-rheumatic drugs, disease-modifying, natural history of active rheumatoid mistaken for injury, (L) 258
arthritis over 3-6 months — an analysis of patients enrolled into trials, 463 Salmonella septic arthritis in HIV patients, (L) 88
GENERAL INDEX
Arthritis and Rheumatism Council Autoimmunity, SCID mouse as vehicle for study, 4
communication channels — the role of the honorary medical secretaries, Autoradiographic localisation of endothelin-1 binding sites in diffuse systemic
(E) 947 sclerosis, (A1) 21
funding priorities, (L) 82 Autoreactivity in patients with Behcet’s disease, 908
guidelines for preparing a grant proposal for a clinical research project, Avascular necrosis of the hip in systemic lupus erythematosus: role of magnetic
1023 resonance imaging, 972
national family material repository, (E) 443 Averns HL. Granulocyte colony stimulating factor in drug-induced agranulo-
Arthro-osteitis, a clinical spectrum, 403 cytosis, (L) 1029
Arthrogenous muscle inhibition influence on quadriceps rehabilitation of Aviott LV. Potency ratio — a brief synopsis, (S) 24
patients with early, unilateral osteoarthritic knees, 127 AxrorD JS See Alavi A; Chandola A; Dalziel M; Rees DHE
Arthropathy Axon JMC, Hawey PR, Huskisson EC. Ileal pouch arthritis, 586
acute following stroke — a hospital study, (A2) 55 Ayers AB See Wong WL
of Sjégren’s syndrome, 609 Azapropazone
ARTHUR R See Foley-Nolan D capacity to control cell activation as measured by Pholasin, (A2) 15
Articular cartilage on the mechanisms of efficacy in rheumatoid arthritis, (A1) 45
mechanical conditioning to prevalent stresses, 956 AZorIN L See Marsal S
stiffness and the predominant acting stress levels: implications for the
aetiology of osteoarthrosis, 16 Bacille Calmette-Guerin
Articular chondrocyte proteoglycan synthesis, insulin-like growth factor immunotherapy for carcinoma of the bladder: a report of two cases of
stimulation. Availability and responses at different ages, 1037 reactive arthritis, 1018
Articular index, self-report: relationship to variations in mood and disease treatment for superficial bladder carcinoma, Reiter’s syndrome after, 1096
activity measures, 631 Back pain
ARTLETT C, VANACHEESWARAN R, BLAck C, Briccs D, WeLsH K. VNTR and abnormal fibrinolysis, (L) 853
TRA analysis of scleroderma family DNA, (A1) 92 chronic idiopathic mediastinal fibrosis presenting with malaise, pleuritis
ArviLomMI HS See Jokinen EI and thoracic back pain, 757
Asuany D See Elkon KB chronic low, abnormal fibrinolysis, (L) 764
ASHERSON R See Ehrenstein MR clinical and radiological study in rheumatoid arthritis, 216
ASHTON BA See Ashton IK height and occupation in a national prospective study, 911
Asuton IK, Linpsay D, Sanota V, ASHTON BA. Substance P, CGRP, bradyki- hospital treatment for, (L) 854
nin and VIP effects on osteogenic precursor cell in vitro, (A1) 95 Back trouble, smoking as cause, 239
Assay of pyridinium crosslinks in serum and synovial fluid using ion- paired BACKMAN K See Jonsson R
reversed-phase high-performance liquid chromatography (HPLC), (A1) Bacon PA See Adu D; Allen ME; Farr M; Johnson AE; Kitas GD; Luqmani
160 RA; Moots RJ; Roussou E; Salmon M; Tunn EJ
Assessment Bacterial antibody levels and faecal flora in rheumatoid arthritis patients
of endothelial cell function under reduced oxygen tension, (A1) 21 taking sulphasalazine, 683
of a modified health assessment questionnaire as an index of function BaDLey EM, TENNANT A. Disablement associated with rheumatic disorders in
status in rheumatoid arthritis, (A1) 121 a British population: problems with activities of daily living and level of
of radiological changes of osteoarthritis in hereditary arthro- ophthalmo- support, 601
pathy (Stickler syndrome), (A1) 142 BaDLey EM See Tennant A
of response of Paget’s disease to pamidronate using the half-life of change
Barron! L. True positive anti-HCV tests in rheumatoid arthritis, (L) 349
in alkaline phosphatase, (A2) 42 BaiLpaM EM, Hott PJL. Association between physical function and psycho-
of T-cell receptor alpha/delta and beta loci contribution to rheumatoid
logical problems in children with juvenile chronic arthritis, (A1) 136
arthritis susceptibility using new highly polymorphic markers, (A1)
Ba.int G. Letter from Hungary, 822
117
BALLARD HS, Nyamuswa G. Life-threatening haemorrhage in a patient with
Association
rheumatoid arthritis and a lupus anticoagulant coexisting with acquired
between bone scans and synovial fluid biochemistry in osteoarthritis of the autoantibodies against Factor VIII, 515
knee joint, (Al) 159
Basa A See Dixey J; Llorente MJ; Mufioz-Fernandez S
between physical function and psychological problems in children with
Bancrort A See Maple C
juvenile chronic arthritis, (A1) 136
BANKHEAD C See O'Neill TW; Symmons DPM
of HLA DR B alleles with self-limiting and persistent forms of early sym-
metrical polyarthritis, 628 BANKHEAD CR See Barrett EM
of HLA-DRB1*0101 and DRB1*1001 with rheumatoid arthritis in BankowsKkA UZ See MacDonald AG
Banks R See Beyeler Ch; Platt R
Greeks, (A1) 110
of in vitro immune functions with the severity of the disease in rheumatoid BANos JE See Rodriguez A
arthritis, 550 BansaL AS See Wilson PB
of rheumatoid arthritis with DR4-Dw15 and DR10 in a Spanish popula- BANSAL S See Ebringer A
BARBADILLO C, MAZZUCCHELLI R, ALONSO PuLPON L, ANpDreu JL, Isasi C,
tion, (A1) 111
Astpury C, BEYELER C, Birp HA. Influence of inflammatory rheumatic disease Pérez A, Mu ero J. Osteoarticular manifestations in heart transplant
on sulphasalazine acetylation, (A1) 53 recipients. A 121 patient study, (A1) 144
Astsury C, BirD HA, Rosinson C, McLaren AM, Rosins SP. Urinary excre- BarBADILLO C See also Andreu JL; Mulero J
tion of pyridinium crosslinks of collagen correlated with joint damage in BaRDHAN KD, Bisarnason I, Scotr DL, GrirFin WM, FENN GC, SHILED MJ,
arthritis, (A1) 159 Moranrt SV. Prevention and healing of acute non-steroidal ant:-inflam-
Astpury C, Piatt R, Dixon JS, Le GALLez P, Hitt J, Birp HA. Optimizing the matory drugs-associated gastroduodenal mucosal damage by misoprostol,
assessment of disease activity during treatment with anti-rheumatic drugs, 990
467 BarDIN T See Worthington J
Astsury C See also Bradley SM; Tait TJ BareFrorD D See Arora RC
ATKINS RM, TINDALE W, BickerstaFF D, Kanis JA. Quantitative bone scin- Barnes CG. European rheumatology, historical perspective, (S4) 10
tigraphy in reflex sympathetic dystrophy, 41 Barnes CG See also O'Neill TW
ATKINS RM See also Warnock MG Barnes J See Hall ND
Atta M See Lim KL Barnett M See Comer M
Attempt to substitute paracetamol for non-steroidal anti-inflammatory drugs Barnett NL See Smith RW
in elderly general practice patients, (A1) 104 BarNSLEY L, Lorp S, THomas P, ALLEN L, SouTHEE A, BoGpuK N. SPECT bone
Auranofin and pyritinol comparison in the treatment of rheumatoid arthritis, scans for the diagnosis of symptomatic cervical zygapophyseal joints, (A2)
375 52
Autoantibodies BARNSLEY L, Lorp S, WALLIs B, BoGpuK N. Double-blind, controlled trial of
and cognitive impairment in systemic lupus erythematosus, 291 intra-articular corticosteroids for chronic cervical zygapophyseal joint
against endothelium, collagen and subendothelial matrix in systemic vas- pain, (A2) 53
culitis, (A1) 22 BARNSLEY L, Lorp S, WALLIS B, BoGpuK N. Chronic cervical zygapophyseal
in central nervous system lupus, 329 joint pain: a prospective prevalence study, (A2) 52
to the nuclear antigen RA33: a marker for early rheumatoid arthritis, 199 Barr K See Bradley SM
Autoimmune rheumatic disease and coexistent primary hyperparathyroidism: Barrett AW, Ross DA, Goopacre JA. Mechanisms of immunity to oral cavity
diagnostic difficulties and treatment implications, (A2) 63 pathogens: function of human oral mucosal Langerhans cells, (A1) 35
Autoimmune thrombocytopenia and rapidly progressive pneumonitis with Barrett EM, BANKHEAD CR, Bunn D, Garin L, LANGRISH-SMITH A, Ivins S,
recurrent pneumothoraces, successful treatment in a patient with rheu- SOMERVILLE M, VAN Poortv tet P, Scorr DGI, SILMAN A, Symmons DPM.
matoid arthritis, (L) 855 Knee involvement in early rheumatoid arthritis, (A2) 5
GENERAL INDEX
Barrett EM, See also O'Neill TW; Symmons DPM Birmingham vasculitis activity score (BVAS), (A1) 85
Barrett NK See Pease CT BisHop J, GREENHAM AK, Lewis EJ. P. acnes induced monarthritis in the rat —
Barry MA, Forster PJC, HAZLEMAN BL, SKINGLE SJ, Crisp AJ. Acquired vita- evaluation of physical, biochemical and radiographic changes, (A1) 42
min D resistant hypophosphataemic osteomalacia — report of 3c ases, (A2) Byarnasson I See Bardhan KD
61 BseELLeE A. European rheumatology, training, (S4) 14
Barry MA, Purser J, HAZLEMAN R, McLean A. Impact of occupational ther- BseE.te A See also Gudmundsson M
apy in patients with rheumatoid arthritis, (A1) 154 Back C See Artlett C; Brennan P; Hasson N
Barry MA See also Hodgson RJ Biack CM See Sinclair HD; Southcott AM; Vancheeswaran R
BaTCHELOR JR. Systemic lupus erythematosus and genes within the HLA Brack D See Hay EM; Teh LS
region, 13 Brack NJ See Carr AJ
BatLLe-Gua.pa E See Esteve-VivesJ Blackcurrant seed oil, cytokine and prostaglandin production by monocytes of
Baum J See Larsson L-G volunteers and rheumatoid arthritis patients treated with dietary sup-
Bax BE See Stevens CR plements, 1055
Bax DE See Peel NFA BiakeE D See Chander C; Grootveld M
Bay.iss MT See Noble DP; Pitsillides AA Bake DR See Abbot SE; Cruwys SC; Edmonds SE; Fairburn K; Garrett NE;
Beacock-SuarP H See Goodall J Harley SL; Jolliffe VA; Mapp PI; Sahinoglu T; Stevens CR; Walsh DA
Beaces LP, EntwistLe A, Brooxs SM, VENABLES PJW, Malini RN. Confocal BLAKEMORE AIF, TarLow JK, Gorpon C, Emery P, Durr GW. Interleukin-1
microscopy for quantitating expression of Epstein-Barr virus RNA in sal- receptor antagonist (IL1RA) gene polymorphism in systemic lupus eryth-
ivary epithelium in Sjégren’s syndrome, (A1) 4 ematosus, (A1) 162
Beaces LP See also Price EJ Biaser KU. Psychiatric disorders in patients with systemic lupus erythemato-
Beattie S See Sant SM sus: lack of association with antiphospholipid antibodies, (L) 646
Becucci A See Pignone A Bietry O See Cacoub P
BeprorD P See Ansell B Blindness in systemic lupus erythematosus, 935
Beeson M See Ansell B BLower PR. Therapy and the 1990s, non-steroidal anti-inflammatory drugs,
Benan D See David J (S4) 35
Behcet's disease BiytH T See Hunter HA
autoreactivity in patients, 908 BiytH TH, Hunter JA. Treatment of the rheumatoid shoulder with intra-
controlled study of sacroiliitis, 693 articular steroid; comparison of superior and anterior routes of injection,
pencil-in-cup deformity, (L) 644 (A1) 69
sex and regional differences in clinical manifestations, (A1) 85 Bop.ey R See Chakravarty K
urate crystal test, (L) 1112 BopMaN K See Sumar N
Betcu JJF. Clinical assessment of the scleroderma spectrum disorders, (E) 353 Boersooms A. Efficacy and safety of radiation synovectomy with yttrium-90: a
Betcu JJF See also Lau CS; Maple C; Veale DJ retrospective long-term analysis of 164 applications in 82 patients, (L)
BeELcHeER C See Ledingham J 1114
Be.t A See Doherty E Boersooms AMT See Kerstens PJSM; van den Hoogen FHJ; van Kasteren
Bett AL, Markey GM, ALEXANDER HD, Morris TCM, McMILLan SA, MEE
McNa tty JA. Myeloperoxidase deficiency in a patient with rheumatoid Boersma JW See Griep EN; Jacobs JWG
arthritis: oxygenation and radical activity by phagocytic cells, 162
BocpukK N See Barnsley L; Mercer S
Bet AL See also Magill MK; Murphy EA
Borarp1 L See Macchioni P
Bet J See Worthington J Boivin CM See Moots RJ
Beit JI See Salmon M
Boxi K See Carthy D
BELTRANDI E See Macchioni P
Bo._en SR, WriGut V. Radiographic changes in the hands of rock climbers,
Ben-Cuetrit E. Molecular basis of the SSA/Ro antigens and the clinical signifi-
(Al) 81
cance of their autoantibodies, 396
BomBarbieR C. Optimal use of cyclosporin A in rheumatoid arthritis: efficacy
Benign synovitis of the hip in adults, 820
and outcome measures including quality of life, (S1) 47
Benso L See Aicardi G
Bercin C See Abuzakouk M Bonpb A See Adebajo AO; Alavi A
Berisa F See Adu D Bone
BERNSTEIN R See Brennan P aluminium-related disease presenting with calcaneal stress fractures, (L)
260
BERNSTEIN RM See Brand SR; Davies EJ; Hay EM; Jones PBB; Kay RA; Ray
DW; Teh LS formers — positive correlations between osteophyte and enthesophyte for-
Bertoucu J See Calin A mation, (A2) 51
BetHat JA See Camilleri JP mass loss documented in hands of patients with early rheumatoid arthritis,
Beyveer C See Astbury C (A2) 4
BeYELER Cu, Banks R, THompson D, Birp HA. Increased total alkaline phos- metabolism in rheumatoid arthritis: relation to disease activity, 387
phatase (TAP) in rheumatoid arthritis: is it due to bone or other iso- pain in infantile myofibromatosis: a cause of in a neonate, 849
enzymes, (A1) 44 reversibility of glucocorticoid induced axial loss, (A1) 130
BeyYecer Cu, Lepse C, REICHEN J, GERBER NJ. Intraindividual variability of bio- tumour diagnosis with metoxiisobutilisonitrile-Tc99 isotopic scan. A use-
availability of low dose methotrexate after oral administration in rheu- ful tool in diagnosis, (A1) 131
matoid arthritis, (A1) 58 Bone density
Beynon HLC, Davies KA, Gaskin G, HAskarp DO, Pusey CD, WALPort MJ. screening in osteoporosis, HRT and the menopause; attitudes and experi-
IgG from P-ANCA positive patients with small vessel vasculitis will acti- ence of perimenopausal women, (A1) 128
vate neutrophils and induce an increase in endothelial permeability, (A1) studies in Turner’s syndrome, (A2) 38
17 Bone density measurement
Beynon HLC, Davies KA, Haskarp DO, Wacport MJ. CR1 on erythrocytes can it be cost effective as an aid to decision making for long- term pre-
inhibits immune complex-induced neutrophil activation and increased scription of HRT, (A2) 40
endothelial permeability, (A1) 8 relationship between lumbar measurements and spinal osteoarthritis,
Buakta B See Pease CT (Al) 132
BHALLA AK See Frost NA; Leong KH; McCloskey EV; Mitra D Bone marrow hypoplasia, systemic-onset juvenile chronic arthritis, 78
Buaracuarya SS See Samanta A Bone mineral density
BiaGini M See Pignone A changes in early rheumatoid arthritis, (A1) 129
Biasi D. Increased secretion of norepinephrine after intravenous gamma comparison in rheumatoid arthritis patients taking corticosteroids orally,
globulin therapy in a patient with rheumatoid arthritis, (L) 1026 intramuscularly or not at all, (A2) 41
BickerstarF D See Atkins RM comparisons of peripheral and axial with bone ultrasound in post-meno-
BickerstaFF DR, CHARLESWORTH D, Kanis JA. Changes in cortical and trabec- pausal women with rheumatoid arthritis on long-term cortico-
ular bone in algodystrophy, 46 steroids, (A2) 40
BieMonD I See Janssen M measurements and broadband ultrasound attenuation in women and men
Butsma JWJ See Jacobs JWG; Lafeber FPJG; Lems WF: van den Brink with vertebral fractures, (A2) 39
MJG; van der Heide A short term changes in perimenopausal women, (A2) 39
Bitcic A, Tutruncu ZN, Kennepy LG, Catin A. Interleukin-6, acute phase BootuBy M See Zebouni LNP
reactants and clinical status in ankylosing spondylitis, (A1) 165 BootsMaA H See van den Hoogen FHJ
BILLINGHAM MEJ See Hicks CA; Kingston AE Bora AA. Measures of pain and disease activity in rheumatoid arthritis, (L)
Binper A See Ebringer A 1028
Birp HA See Astbury C; Beyeler Ch; Bradley SM; Fraser SM; Hill J; Isdale Bora AA, FIsHERJ ,C LARKE S, Mattey DL, Dawes PT. IgA antibodies to cytok-
AH: McLaren AM; Platt R; Tait TJ eratin-18 and measures of disease activity in rheumatoid arthritis, (A2) 9
GENERAL INDEX
Borc AA, FitzGeraLD DA, HeEaGarty AHM, Dawes PT, Marrtey DL. IgA Brucués J See Kanterewicz E
antibodies to cytokeratins and patterns of psoriatic arthritis, (A2) 26 BRUMMELKAMP EP See Kerstens PJSM
Borc AA See also Close DR; Plant MJ Brzeski M See Murphy EA
Borrelia burgdorferi BUCHANAN N See PoulJ
infection and polymyalgia rheumatica, (L) 523 BUCKLAND-WRIGHT JC See Macfarlane DG; Szebenyi B
screening for antibodies to in patients with symptoms compatible with BUCKNALL RC See Phelan MJI; Pirmohamed M
Lyme borreliosis, (A2) 27 Bunn D See Barrett EM
Boscu F See Rodriguez A BurMESTER GR See Horneff G
Boswe.t R See Croft PR Burney R, PILE K, Cornei s F, Liore F, Worpswortu P. Instructional model
Botes D See Halland AM for the detection of non-HLA susceptibility loci in rheumatoid arthritis,
Both inherited HLA-haplotypes are important in the predisposition to rheu- (A1) 108
matoid arthritis, 893 Burney RO See Pile KD
Bourke BE. Central nervous system involvement in systemic lupus erythema- Burrow C See Phelan MJI
tosus. Are we any further forward, (E) 267 BuskiLa D See Nyska M
Bourke BE See Collins DA; Laversuch CJ Butt P See Hordon LD
Bourne J See Foley-Nolan D Butt WP. MRI of the appendicular skeleton, (E) 945
Bourne JT See Akil M; Donnelly S Butters R See Carr AJ
BowmaN SJ, Boyiston A, Panay GS, LANcuBury JS. T cell receptor repertoire Byars ML, McGILt P, KELMAN AW. Cytokine and prostaglandin production by
in patients with rheumatoid arthritis and neutropaenia, (A1) 89 monocytes of volunteers and rheumatoid arthritis patients treated with
Boyiston A See Bowman SJ dietary supplements of blackcurrant seed oil, 1055
Bozzone P See Stucki G Byrne J, Goucu A, Dacre JE, Devuin J, EMery P, James MF. Measurement of
Brapsury N See Jones A radiographic joint space loss in early rheumatoid arthritis using digital
BraD_ey SM. Faecal Clostridium perfringens and antibody responses to its image analysis: correlation with hand function, (A2) 45
antigens in arthritis patients on and off non-steroidal anti- inflammatory Byrne J, HEALD G, James MF, Sorter JH, Dacre JE. Measurement of patello-
drugs, (L) 940 femoral joint space using digital image analysis, (A1) 82
BraD.ey SM, Gooi HC, Birp HA. Effect of non-steroidal anti- inflammatory Byrne J, Jawep S, James MF, Dacre JE. Radiographic tibiofemoral joint space
drugs on bacterial antibody levels and faecal flora in arthritis, (A1) 48 changes over 5 years in patients with knee pain and correlation with clini-
BRADLEY SM, NEUMANN VC, Barr K, TROUGHTON PR, Astpury C, Birp HA, cal findings, (A2) 44
Goo1 HC, Wricut V. Sequential study of bacterial antibody levels and Byrne J See Phelan MJI
faecal flora in rheumatoid arthritis patients taking sulphasalazine, 683 Byron M See Chakravarty K
BRAGANZA JM See Herrick AL
Cl-inhibitor
BRAMMAH T, Hapipy K, GusH R, Jayson MIV. Sympathetic dysfunction syn-
drome in chronic referred lower limb pain, (A1) 78 and inhibition of the inflammatory response in RA, (A1) 6
Brancos MA See Peris P interaction of plasmin with, (A1) 7
Clq antibody measurement by ELISA using purified collagen stalks from the
BRAND SR, BERNSTEIN RM, MatHews MB. Human proliferating cell nuclear
molecule as the solid phase ligand, (A1) 7
antigen forms a trimer that correlates with its ability to be recognized by
C reactive protein levels - comparison between general medical and rheu-
human auto-antibodies, (A1) 91 matology patients, (A1) 36
Branpi L See Olgaard K
Cacous P, Musset L, LUNEL FaBIANi F, PERRIN M, LeGerR J-M, Tot HuonG DU
Brass A See Worthington J
L, WECHSLER B, BLetry O, Opo.on P, Huraux J-M, Piette J-C, Gopeau P.
Braun J See Sieper J
Hepatitis C virus and essential mixed cryoglobulinaemia, 689
BRECKENRIDGE AM See Pirmohamed M
CAHILL MR See Gaffney K
BREEDVELD FC See Eggelmeijer F; Landewé RBM; Markusse HM; van Schaar-
CAHILL R See Sant SM
denburg D; Vliet Vlieland TPM Caxir N. Urate crystal test in Behcet’s syndrome, (L) 1112
BRENCHLEY PEC See Snowden N CaLaBozo M See Alonso-Ruiz A; Perez-Ruiz F Calcitonin gene-related pep-
BRENNAN FM See Elliott MJ tide II, substance P and vasoactive intestinal peptide in plasma and syn-
BRENNAN P, MacGrecor A, SILMAN A. Reproduction and hormonal differ- ovial fluid from patients with inflammatory joint disease, 31
ences in female twins discordant for rheumatoid arthritis, (A1) 114 Calcium pyrophosphate
BRENNAN P, SitMAN A, BLack C, BERNSTEIN R, Coppock J, MAppison P, deposition disease — involvement of the acromioclavicular joint with
SHEERAN T, STEVENS C, WoLLHEIM F, UK ScLERODERMA StuDy Group. pseudocyst formation, 248
Validity and reliability of three methods used in the diagnosis of Ray- dihydrate crystal deposition disease, (E) 177
naud’s phenomenon, 357 CALDER L, Garton MJ, Reip DM. Is etidronate effective in corticosteroid-
BRESNIHAN B See Doherty E; Mulherin D; Nasser SM; Yanni G induced osteoporosis? — a case control study, (A1) 129
BrivGer J See Ray DW Ca.in A, DouGapbos M, VAN Der LINDEN S, LeirIsALO-REPo M, HurtFecp B,
Briccs D See Artlett C; Hasson N BerTOUCH J, Brooks P, EpMonps J, Masor G, KviEN T, Ouiviert I, Veys E,
BRIGHTON SW, LusBe JE, VAN DER Merwe CA. Effect of a long-term exercise ZEIDLER H, Amor B. Double-blind multi-centre placebo controlled study
programme on the rheumatoid hand, 392 of sulphasalazine in 351 patients with spondylarthropathy, (A1) 103
British Paediatric Rheumatology Group news, 68, 424, 835 Ca.in A, Garrett SL, Hirst S, KENNEDY LG. Controlled prospective study of
British Society for Rheumatology, meeting report, 762 the sex ratios among relatives of patients with HLA-related diseases: dis-
Broan JE See Gudbjérnsson B tinct patterns in ankylosing spondylitis and sero negative rheumatoid
Broncheoalveolar lavage in rheumatoid arthritis, 556 arthritis, (A1) 63
Bronchiectasis Cauin A See also Bilgic A; Garrett SL; Jenkinson TR; Kennedy LG; Mallorie
and rheumatoid arthritis: potential pitfalls in interpretation, (L) 264 PA; O’Neill T; Pile KD
HLA associations in subjects with rheumatoid arthritis and bronchiectasis CALIN SA See Garrett SL
but not with other pulmonary complications of rheumatoid disease, CALLAHAN LF See Pincus T
794 CaLverR D See Nasser SM
younger onset of rheumatoid arthritis, (A1) 125 Catvo-ALEN J, De Cos MA, Escatapa R, Arias M, RopriGUEZ VALVERDE V.
Bronchiolitis obliterans, non-fatal, possibly associated with tiopronin. A case Nephrotoxicity in rheumatic patients on long-term therapy with non- ste-
report with long-term follow-up, (L) 172 roidal anti-inflammatory drugs, (A1) 58
Bronchoalveolar lavage in lifelong non-smoking rheumatoid arthritis patients, CAMBRIDGE G, WiLLIAMs M, LEAKER B, Corsett M, Smitu CR. Incidence, IgG
(A2) 3 subclass and clinical correlates of anti-myeloperoxidase antibodies in sera
Brookes SM See Price EJ; Wilde NT from patients with rheumatoid arthritis, (Al) 17
Brooks P See Calin A CampBriDGE G See also Fairburn K; Longhurst C; Smith CR
Brooks SM See Beales LP CAMBRIDGE J, WILKINSON L, LEAKER B, Epwarps J. Immunoreactive myelope-
Bropuy D See Cunnane G roxidase in rheumatoid synovia and nodules: relationship to peroxidase
Brown CM See Moyes SP activity, (A2) 13
Brown DL See Pountain GD CaMILLEN J See Gibson K
Brown KA, Perry MA, MustapHa Y, Woop SK, Dumonpe DC. Relationship CAMILLERI JP, Jessop A, Davis S, JessopJD , HALL MH. Survey of work capacity
between lymphocyte infiltrates and high endothelial cells in rheumatoid in rheumatoid arthritis, (A2) 58
synovium, (A1) 20 CamMILLeR! JP, Lewis PA, Wittiams BD, O’SuULLIVAN MM, Betuet JA, Ros-
Brown M See Rees DHE INSON M, Emery P, Wittiams LA, Jessop JD. Serum sIL-2R disease activ-
Brown MA. Aluminium-related bone disease presenting with calcaneal stress ity and progression in rheumatoid arthritis, (A1) 164
fractures, (L) 260 CamiLert JP, Wittiams AS, Amos N, DouGtas-Jones AG, WitLiaMs BD. Tar-
Brown NS See Lim KL geted in vivo macrophage depletion using liposome encapsulated bisphos-
Brown S See Lim KL phonates, (A1) 41
GENERAL INDEX
CAMPATH-1H Central nervous system
high dose therapy in rheumatcid arthritis, (Al) 54 inflammation in the eosinophilia-myalgia syndrome, (L) 174
preliminary experience with single infusion in the treatment of refractory involvement in systemic lupus erythematosus. Are we any further for-
rheumatoid arthritis, (A1) 54 ward, (E) 267
in the treatment of rheumatoid arthritis, (A2} 21 Ceron A See Aragon A
CampBeLt A See Phelan MJI CeERVERA R See D’Cruz D
Can a measurement of bone density be cost effective as an aid to decision mak- Cervical synovial joints, intra-articular inclusions, 705
ing for long-term prescription of HRT, (A2) 40 CHAKRAVARTY K. Leucopenia, an unusual presenting feature in primary
Cape.tt HA See Fraser SM; MacDonald AG; McInnes I; Murphy EA; Porter systemic vasculitis, (L) 432
DR Cuakravarty K. Q-fever polyarthritis, (L) 346
Capillary electrophoresis with fluorescence detection: assay of pyridinium and CHaKravarty K, AL-HiLLtawi AH, Durkin CJ, BopLey R, Wesey M. Acute
pentosidine crosslinks, (A1) 160 arthropathy following stroke — a hospital study, (A2) 55
Caporat R See Montecucco C Cuakravarty K, Goya M, Scorr DGI, McCann BG. Malignant angioen-
Carboxyterminal type I procollagen peptide concentrations in systemic scler- dotheliomatosis (intravascular lymphomatosis), an unusual cutaneous
osis: higher levels in early diffuse disease, 59 lymphoma in rheumatoid arthritis, 932
"ARLISLE L See Nisar M CHAKRAVARTY K, Merry P, Scott DGI. Treatment of Paget’s disease with single
“ARPENTER TA See Hodgson RJ infusion of intravenous APD — a longitudinal study, (A2) 42
‘arR AJ, Butrers R, Gunn F, Biack NJ, Cox NL. Efficacy of a multidisci- CHAKRAVARTY K, PounTAIN G, BYRON M, HAZLEMAN BL, Merry P, Scott DGI.
plinary pain management group in helping people with rheumatoid arthri- Prevalence and clinical significance of cardiolipin antibody and ANCA in
tis cope with chronic pain, (A1) 153 polymyalgi.. rheumatica and giant cell arteritis — a longitudinal study, (A2)
“arR AJ, PLayrairk C, THOMPSON PW. Use of non-steroidal anti-inflammatory 35
drugs in chronic conditions: a survey of prescribing patterns in a semi-rural CHAKRAVARTY K See also Symmons DPM; Watts RA
general practice, (A1) 50 CHALLACOMBE S See Cauli A
“ark AJ, THomMPSON PW, Cox NL. Patient-perceived impact of rheumatoid CHAMBERLAIN A See Hart DJ
arthritis, (Al) 152 CHAMBERLAIN MA, Rosertson RJH. Controlled study of sacroiliitis in Beh-
“ARR AJ, THOMPSON PW, Cox NL. Self reported functional disability in rheu- cet’s disease, 693
matoid arthritis: comparison with the MACTAR patient function prefer- CHAMBERLAIN MA See also Foley-Nolan D; Green J; Helliwell PS; Hordon LD;
ence questionnaire, (A1) 122 Taylor PV; Tennant A
“arr J. Isolated myelopathy as a presentation of polyarteritis nodosa, (L) 644 Cuampers J See Yanni G
“ARRUTHERS D See Watts RA Cuameers TJ See Collins DA; Tobias JH
"ARTER R See Porter DR Cuan KL See Cohen MG
“ARTHY D, OLLIER W, PaPAsTERIADES C, Bok K, THOMSON W. Association of CHANDER C, Dow Linc E, CLaxson A, Panetta J, BLake D. Effects of
HLA-DRB1*0101 and DRB1*1001 with rheumatoid arthritis in Greeks, LY¥221068 and indomethacin on luminol-amplified chemiluminescence in
(Al) 110 a model of cell-mediated inflammation, (A1) 46
“arTHY D See also MacGregor AJ; Silman AJ; Thomson W; Wilson PB CHANDER C See also Grootveld M
‘artilage CHANDOLA A, MCALIsTER J, AxForD JS, YounG Y. Do patients with rheu-
conditioning of properties: does cartilage stiffness adapt to prevalent matological diseases consider alternative therapies, (A2) 60
stress, (Al) 120 Cuanpy J See Rai A
degradation by elastase activity of rheumatoid synovial fluids, (A1) 118 Changes
human articular, effect of rhIL-1 and rhTGH6 on glycosamin chain syn- in antinuclear serology in patients with spondylarthropathy under sul-
thesis and UDP-glucose dehydrogenase activity, (A1) 120 phasalazine treatment, (L) 521
matrix biochemical composition, gender differences in rat, (Al) 118 in bone mineral density in early rheumatoid arthritis, (A1) 129
oligometric matrix protein: a novel marker of cartilage turnover detect- in cortical and trabecular bone in algodystrophy, 46
able in synovial fluid and blood (Erratum Vol 31:583), 247 in PDGF-B in systemic sclerosis, (A2) 33
response to interleukin-1, gender differences, (A1) 119 in spinal stiffness due to nonspecific mechanical low back pain, (A1) 70
role for IL-1 in the diminished responsiveness to IGF-1 in a murine model CuapMaNn B See Swan AJ
of arthritis, (A1) 119 CuapMaNn C See Kendall R; Longhurst CM
“ASADEI-MALDINI M See Macchioni P Characterisation
“ase of a 26/23 kD polypeptide doublet recognised by anticentromere positive
of reactive arthritis following exposure to industrial gases and oils, (L) 438 patients, (A1) 11
of steroid-responsive organizing pneumonia in a patient with rheumatoid of antiendothelial cell antibody binding in lupus nephritis, (A1) 23
arthritis showing migratory infiltration and normal glucose levels in Charcot arthropathy as an unusual initial manifestation of diabetes mellitus,
pleural effusions, 829 (L) 854
asEY E See Abuzakouk M; Wallace E CuarbD MD See Pountain GD
asEY EB See Arora A; Kelleher D Cuar es P See Elliott MJ; Foster H
astro T See Solans R Cuar_es PJ See Hogg AM; Pease CT; Teh LS
ASTRO-GUARDIOLA A, SIMEON CP, FonoLiosa V, CLEMENTE C, ARMADANS LI, CHARLESWORTH D See Bickerstaff DR
Soians R, ALzaGa X, ALONSO F, VILARDELL M. Systemic sclerosis in men: CHASSAGNE PH, MesJjAD O, GouRMELEN O, Moore N, Le Loer X, Desnayes P.
clinical and immunological features, (A1) 88 Exacerbation of systemic lupus erythematosus during human parvovirus
asTRO-SALOMO A See Selva A B19 infection, 158
atalase activity, evidence for reduced in rheumatoid synovial fluid, (A1) 158 Cuatropapuyay C See Hillarby MC; Isdale AH
arty D See Ahmad A CHENG AF Sce Li EK
auL! A, YANNI G, CHALLACOMBE S, PaNnayi GS. Patterns of cytokine CHESSBROUGH MJ See Helliwell PS
expression and mononuclear cell infiltration in the minor salivary glands CHEUNG NT See Ahmad A
of patients with Sjégren’s syndrome, (A1) 168 CHEVALIER X. Salmonella lomita spondylodiscitis, (L) 768
AVANAGH G See Deighton CM CHIKANZA IC, Petrou P, CHrousos G, KincsLey G, Panayi GS. Excessive and
AVE M See Vecchio P dysregulated secretion of prolactin in rheumatoid arthritis: inmunopath-
AwLEY MID See Cook NJ; Jenkins EA; Smith RW; Wong WM ogenetic and therapeutic implications, 445
AWSTON TE See Clark IM Childhood arthritis
B-11 peptide of type II collagen epitopes recognized by antibodies from disease education video, (A1) 133
patients with rheumatoid arthritis, 658 the name game, 421
D8 and CD57 expression in rheumatoid synovium: histological relationship - the name of the game, (L) 1115
with B cells, (A2) 12 Chirico S See Edmonds SE
D23 elevation in lupus and other nephritides, (A1) 26 Chlamydia pneumoniae as a cause of reactive arthritis, (L) 1112
D23 in monozygotic and dizygotic twins discordant for rheumatoid arthritis, Chlormezanone in primary fibromyalgia syndrome: a double blind placebo
(Al) 26 controlled study, 55
D44 expression Chondrocalcinosis
and cytokines by synovial fibroblasts, (A2) 11 does hypothyroidism increase prevalence, 197
and molecular weight polymorphism in rheumatoid synovial fluid lym- tendon calcifications of the hip adductors: a radiological study of 75
phocytes, (A1) 27 patients, 790
reduced in rheumatoid synovial cells, (A1) 25 Chondrocytes, production of active oxygen species, 562
Cell-cell contact reveals IL-4 presence in RA via SCD23 elevation, (A2) 15 Cuoonc K See Jaworski R
Cellular regulatory mechanisms that may underlie the effects of cortico- Cuowprey HS, Licutman SL. Interaction between the neuroendocrine system
steroids on bone, (S2) 6 and arthritis, (E) 441
GENERAL INDEX
Cuowprey HS See also Sarlis NJ CoHEN M See Jones SM
Cuoy E, Kincs-ey G, Panay G. Systemic sclerosis occurring in a patient with Counen MG, Li EK, Ne PY, Cuan KL. Extra-articular manifestations are
Adamantiades-Behg¢et’s disease, 160 uncommon in Southern Chinese with rheumatoid arthritis, 209
Cuoy E See also Yanni G CouHEN MG See also Li EK
Cuoy EHS, Apiaye J, Forrest L, KiIncsLey GH, Panay GS. Apoptosis or pro- Cold water, possible danger, (L) 525
grammed cell death of human lymphocytes caused by anti-CD4 mono- CoLEeMAN MD See Pirmohamed M
clonal antibody, (A1) 90 Collagen
Cuoy EHS, Kincs.ey GH, CorkiLt MM, Panay GS. Intramuscular methylpre- antibodies to type II in early rheumatoid arthritis
dnisolone is superior to pulse oral methylprednisolone during the induc- antibody-positive rheumatoid arthritis patients, frequency of alleles of
tion phase of chrysotherapy, 734 type II collagen, (L) 1117
Cuoy EHS, Kincstey GH. Immunotherapy, past, present and future, (E) 89 induced arthritis prevention in mice by deletion of T cell receptor VB8
Cuoy EHS, Pirzais C, Kincs_ey GH, Panay GS. Daily treatment with chi- bearing T cells with monoclonal antibodies, 26
maeric anti-CD4 monoclonal antibody: clinical and immunological pyridinium crosslinks, physiological variations in the urinary excretion,
response in peripheral blood and synovial fluid, (A1) 55 307
Chronic cervical zygapophyseal joint pain: a prospective prevalence study, type I defect in a family with osteoporosis, psoriasis and spondylarthro-
(A2) 52 pathy, (A1) 44
Chronic idiopathic mediastinal fibrosis presenting with malaise, pleuritis and urinary excretion of pyridinium crosslinks correlated with joint damage in
thoracic back pain, 757 arthritis, (A1) 159
Chronic lupus peritonitis responsive to treatment with cyclophosphamide, (L) COoLLANTES E, Tinanones FJ, CisNat A, SANCHEZ P. Influence of the usual
1116 alcohol intake on uricemia, (A1) 148
Chronic polyarthritis due to Pseudomonas aeruginosa, 1021 Cottantes E See also Tinahones FJ
Curousos G See Chikanza IC Co..antes Estévez E See Acasuso Diaz M
Chrysiasis: clinical and patholog:cal study, (A1) 51 Co.uins CE See Gaffney K
Cuua A See Arora A Couns DA, CHamsers TJ. Leukotrienes B,, C, and D, induce osteoblastic
Churg-Strauss syndrome, paranasal sinus appearances on computed tomog- cells to stimulate osteoclastic bone resorption, (A1) 43
raphy, (A1) 80 Co..ins DA, LaversucH CJ, Bourke BE. Psychiatrists vision of SLE: occult
Cimetidine, lack of interaction with sulphasalazine in patients with rheumatoid SLE in the psychiatric community, (A2) 31
arthritis, 222 Co.uins DA, Tosias JH, Hitt RP, Bourke BE. Reversal of gold-induced neu-
Cimino MA. Polymalgia rheumatica and Borrelia burgdorferi infection, (L) tropenia with granulocyte colony-stimulating factor (G-CSF), 518
523 Coins DA See also Laversuch CJ
Circulating lymphocyte subsets A) in polymyalgia rheumatica/giant cell arter- Cotston MJ See Hicks CA; Kingston AE
itis, and B) in healthy volunteers taking prednisolone, (A2) 36 Cotter C See Stokes MJ
CisNAL A See Collantes E; Tinahones FJ CoLver SE See Peel NFA
CLAGUE RB See Morgan K Combination therapy
CarK D, LamBert CM, PALMER K, STRACHAN R, Nukt G. Monoarthritis caused approaches to the management of rheumatoid arthritis, (S1) 24
by Mycobacterium avium complex in a liver transplant recipient, 1099 in RA: pharmacokinetic analysis of the interaction between methotrexate
Ciark IM, PoweLt LK, Ramsey S, HAZLEMAN BL, Cawston TE. Measure- and sulphasalazine, (A1) 59
ment of collagenase, tissue inhibitor of metalloproteinases (TIMP) and Comer M, Barnett M, Scott DL, DoyLe DV, Hopkins A. Acute hot joint: pro-
collagenase-TIMP complex in synovial fluids from osteo- and rheumatoid cess and outcome audit, (A1) 156
arthritis, (A1) 93 Comer M, Scott DL, DoyLe DV, Huskisson EC, Hopkins A. Monitoring slow
CLarKE AK. Rheumatoid arthritis, impairment and mobility, (E) 1035 acting anti-rheumatic drugs: time for change, (A1) 106
CiarkE AK See also Regan M Comer M, Scott DL, DoyLe DV, Huskisson EC, Hopkins A. What determines
CiarKE F, Foster H, McDonacu JE, Piatr PN. Gout in cardiac transplant the intervals for monitoring second line drugs, (A1) 155
patients, (Al) 144 Comer M See also Storey GO
CLARKE F, McDonacu JE, PLatr PN. Evaluation of a computerised expert Communication channels of the Arthritis and Rheumatism Council — the role
system for the monitoring of second line drugs, (A1) 155 of the honorary medical secretaries, (E) 947
CrarkE S See Borg AA; Hassell AB Comparative study
CLARKSON RWE See Hillarby MC; McMahon MJ in the magnitude of response of sulphasalazine and penicillamine in early
Ciaxson A See Chander C; Grootveld M rheumatoid arthritis, (A2) 18
CLEMENTE C See Castro-Guardiola A of satisfaction in a rheumatology out-patient clinic, (A1) 150
CLements D See Cooper AM of serum deaminases in systemic rheumatic diseases, (L) 1118
Clinical and radiological study of back pain in rheumatoid arthritis, 216 Comparison
Clinical and serological autoimmune dysfunction in patients treated with sul- of bone mineral density in rheumatoid arthritis patients taking cortico-
phasalazine, (A1) 52 steroids orally, intramuscularly or not at all, (A2) 41
Clinical assessment of the scleroderma spectrum disorders, (E) 353 of guanethidine blocks and epidural analgesia in longstanding algodystro-
Clinical effects of intra-articular yttrium-90 and steroid in knee arthritis, (A2) phy of the lower limb, (A2) 53
op) of peripheral and axial bone mineral density with bone ultrasound in post-
Clinical features and outcome of cases of septic arthritis presenting to a single menopausal women with rheumatoid arthritis on long-term cortico-
English Health Authority: is arthroscopy detrimental, (A2) 28 steroids, (A2) 40
Clinical spectrum of synovitis—acne—pustulosis—hyperostosis—osteomyelitis of pyritinol and auranofin in the treatment of rheumatoid arthritis, 375
syndrome, (L) 1114 of synovial lining cells with palisading cells in rheumatoid nodule and sur-
Clinical study of rheumatoid arthritis in South Indians in Hyderabad, (A2) 62 face cells in regenerate synovium, (A1) 95
Clinical Terms Project and rheumatology, (A1) 149 of the HLA-DR associations of Welsh and English patients with rheu-
Clinical trials of osteoarthritis therapies, (E) 529 matoid arthritis, (A1) 111
Ciose DR, StaNwortH DR, Bora AA, Dawes PT, Marrtey DL. Natural killer of three different physiotherapy regimes in ankylosing spondylitis, (A1)
cell activity in rheumatoid arthritis. Influence of the IgA-alpha-1-anti- 103
trypsin complex determined by a conjugate-binding cytotoxicity assay, Complement C3 gene, identification of regulatory regions around, (A1) 8
(Al) 34 Complement deficiency and disease, 269
Clostridium perfringens Complicated case of systemic lupus erythematosus, 325
abnormal faecal flora in rheumatoid arthritis and other diseases, (L) 939 Compston JE See Cooper AM
faecal, and antibody responses to its antigens in arthritis patients on and Computerised expert system evaluation for the monitoring of second line
off non-steroidal anti-inflammatory drugs, (L) 940 drugs, (A1) 155
CoakLey FV, Samanta A, FINLEY DB. Ultrasonography of the tibialis posterior Computerised measurement of finger joint space in hand radiographs, (A2) 43
tendon in rheumatoid arthritis, (Al) 72 Concordance rates for rheumatoid arthritis in twins: results of a nationwide
Copina R See Selva A study, (A1) 89
Coexistence of intractable nodular rheumatoid arthritis and scleroderma, (L) Conditioning of cartilage properties: does cartilage stiffness adapt to prevalent
82 stress, (A1) 120
Coexistent primary hyperparathyroidism and autoimmune rheumatic disease: Confocal microscopy for quantitating expression of Epstein-Barr virus RNA
diagnostic difficulties and treatment implications, (A2) 63 in salivary epithelium in Sjégren’s syndrome, (A1) 4
Cogan’s syndrome and Peyronie’s disease: a non-fortuitous association, 1111 Connective tissue
CoccGan D See Kuh DJ inherited disorders with scleroderma-like changes: sclerotrophic syn-
Cognitive impairment drome of Huriez, (A2) 63
and autoantibodies in systemic lupus erythematosus, 291 UCTD or U1 RNP-associated syndrome, (L) 348
patterns in patients with systemic lupus erythematosus, 458 Conners G, McGratu M. Nailfold capillary circulation in osteoarthritis, 1062
GENERAL INDEX
Conroy R See Doherty E Crow ey C See Da Silva JAP; James IT
Conroy SE, LarcHMAN DS, Wi_LiaMs WM, IsenBerG DA. Detection of anti- Cruwys SC, Garrett NE, JoLuirre VA, Mapp PI, Bake DR, Kipp BL. Effect
bodies to the 90KDa heat shock protein in patients with SLE and other of denervation on bradykinin responses in chronic arthritis, (A1) 37
autoimmune rheumatic diseases, (A2) 32 Cruwys SC See also Garrett NE; Jolliffe VA; Mapp PI
Conservation of T cell receptor expression by clones specific for a defined Cryoglobulinaemia, essential mixed and hepatitis C virus, 689
MHC/peptide complex, (A1) 105 Cryptic T cell recognition sites in human cartilage aggrecan CS1 region, (A1)
Contraceptive practice in women with systemic lupus erythematosus, 227 15
Contrasting effects of immunosuppression on levels of soluble VCAM-1 in Crystals in equine articular cartilage, (A2) 48
systemic vasculitis and SLE, (A1) 18 Cuesta M See Mufioz-Fernandez S
Controlled comparison of intra-articular healon (hyaluronate) triamcinolone CunDALL D See Foley-Nolan D
and saline in osteoarthritis of the knee, (A1) 61 CunnaNE G, Bropuy D, Gipney R, FitzGERALp O. Use of ultrasonography in
Controlled prospective study of the sex ratios among relatives of patients with the diagnosis and treatment of achillodynia associated with inflammatory
HLA-related diseases: distinct patterns in ankylosing spondylitis and sero joint disease, (A1) 100
negative rheumatoid arthritis, (A1) 63 CUNNINGHAM P See Ebringer A
Controlled study CUNNINGHAM T, FarreLL J, VEALE D, FitzGerALp O. Anterior mediastinal
of hormonal replacement therapy in women with rheumatoid arthritis, fibrosis with superior vena caval obstruction complicating the synovitis—
(Al) 56 acne-pustulosis—hyperostosis—osteomyelitis syndrome, 408
of sacroiliitis in Behcet's disease, 693 CUNNINGHAM VV See Jones AKP
Controlled trial Currey H See Kirwan J
of the effect of topical GTN on skin blood flow and dermal sclerosis on CUSHNAGHAN J, McCartuy C, Dieppe P. Taping the patella medially: a new
scleroderma, (A1) 73 treatment for osteoarthritis, (A1) 105
of pulse vs continuous cyclophosphamide and prednisolone in the treat- CusHNAGHAN J See also Dieppe P; George E; Kassimos D; Lim KKT
ment of vasculitis, (A1) 104 Cutaneous polyarteritis nodosa in human immunodeficiency virus infection,
Cook NJ. Psoriatic arthritis with dyspnoea, (L) 524 (L) 937
Cook NJ, SiLMAN AJ, Propert J, CawLey MID. Features of systemic sclerosis Cutts A See Tennant A
(scleroderma) in an identical twin pair, 926 Cyclophosphamide
Cooper A See Woolley DE and prednisolone, controlled trial of pulse vs continuous in the treatment
Cooper AM, CLeMents D, Evans WD, Evans C, Compston JE, O’SULLIVAN of vasculitis, (A1) 104
MM. Longterm follow up of spinal trabecular bone mineral in women with chronic lupus peritonitis responsive to treatment, (L) 1116
non-steroid treated rheumatoid arthritis, (A1) 132 Cyclosporin A
Cooper AM, Haywarp C, WiLLiaAMs BD. Calcium pyrophosphate deposition in adult dermatomyositis, (L) 439
disease — involvement of the acromioclaviculjoairn t with pseudocyst for- effects on bone and cartilage, (S1) 42
mation, 248 efficacy in rheumatoid arthritis: worldwide experience, (S1) 57
Cooper C See Kuh DJ; McAlindon T; Snow S immunological actions in rheumatoid arthritis, (S1) 38
Cooper RG See Davies EJ; Hillarby MC; Stokes MJ in rheumatoid arthritis: overview of efficiency, (S1) 51
CopLanD RFP See Jawad ASM in rheumatoid arthritis — future perspectives, (S2) 76
Coppo R See Aicardi G in the treatment of relapsing polychondritis with severe recurrent eye
Coppock J See Brennan P involvement, (L) 352
Corsett M, Datton S, Youn A, SILMAN A, SuHiPLey M. Factors predicting international concensus report: use in rheumatoid arthritis, (S1) 1
death, survival and functional outcome in a prospective study of early malignancies in rheumatoid arthritis patients, (S1) 72
rheumatoid disease over fifteen years, 717 nephropathy in patients with rheumatoid arthritis, (S1) 60
Corsett M See also Cambridge G; Smith CR optimal use in rheumatoid arthritis: efficacy and outcome measures
Corpone G See Aicardi G including quality of life, (S1) 47
CorkiLt MM See Choy EHS; Dunbar PR renal morphology after therapy in rheumatoid arthritis patients, (S1) 65
Cormier C. Effects of intravenous aminopropylidene bisphosphonate in Cyclosporine is effective in early rheumatoid arthritis: a randomized double
patients with refractory Paget's disease, (L) 767 blind controlled trial, (A1) 102
CorneLis F See Burney R; Worthington J Cytidine deaminase, a useful marker for differentiating polymyalgia rheu-
Corticosteroids matica from rheumatoid arthritis, (A1) 98
actions as second-line agents, (A1) 51 Cytokeratin demonstration in endothelial cells of the synovial microvascula-
cellular regulatory mechanisms that may underlie the effects on bone, ture in situ and in vitro, 676
(S2) 6 Cytokines
pulse therapy and sIL-2 receptor, IL-6 and IL-8 levels in patients with and anti-cytokines, (S1) 15
rheumatoid arthritis, (A1) 167 and CD44 expression by synovial fibroblasts, (A2) 11
therapy effects on bone mineral density in SLE patients, (A1) 55 and growth factor effects on apoptotic polymorph (PMNL) phagocytosis
Corticotrophin releasing factor binding protein in inflammatory arthritis, (A2) and clearance by normal blood monocyte derived macrophages, (A1)
13 166
Cortisol axis interference by the microtubule antagonist CPH82, 804 and prostaglandin production by monocytes of volunteers and rheu-
Coscrove S See Symmons DPM matoid arthritis patients treated with dietary supplements of black-
CouGHLAN RJ See Srinivasan U currant seed oil, 1055
inter-relationships and their association with disease activity in arthritis,
CCoouuppeLsa npB SCee SeSen oPwadteeln S N (L) 350
Course of established ankylosing spondylitis and the effects of sulphasalazine patterns of expression and mononuclear cell infiltration in the minor sal-
over 3 years, 729 ivary glands of patients with Sjégren’s syndrome, (A1) 168
Cowie MR See de Wit D Cytophagocytic mononuclear cells in rheumatoid synovial fluid (RA- SF) indi-
Cox N See Young A cate a novel form of reactive arthritis, (A1) 93
Cox NL See Carr AJ Cytotoxic therapy in rheumatoid arthritis, (E) 355
CPH82 microtubule antagonist, interference with the cortisol axis, 804 Da Sitva JAP, Larsre J-P, HALL GM, Spector TD. Double-blind controlled
CRI on erythrocytes inhibits immune complex-induced neutrophil activation study of testosterone therapy in male rheumatoid arthritis, (A1) 50
and increased endothelial permeability, (A1) 8 Da Sitva JAP, Larsre JP, James IT, Crow.ey C, Moore AR, Scott DL, Wiz-
Crart J See McHugh NJ LouGuBy DA. Gender differences in rat cartilage matrix biochemical com-
CrawrorD A See Dearman MS position, (A1) 118
Creep F See Hay EM; Teh LS Da Siva JAP, Larsre JP, Moore AR, Spector TD, Scorr DL, WiLLOUGHBY
CREEMERS M, VAN Riet P, FRANSSEN M, VAN “T Hor M, Van De Putte L. Dutch DA. Gender differences in cartilage response to interleukin-1, (A1) 119
functional index for ankylosing spondylitis, (A1) 64 Da Sitva JAP See also Larbre JP
Cremona A See North J Dacre JE See Byrne J; Griffith SM
CREST syndrome, sclerotherapy as treatment of recurrent bleeding from Daily treatment with chimaeric anti-CD4 monoclonal antibody: clinical and
upper gastrointestinal telangiectasia, 760 immunological response in peripheral blood and synovial fluid, (A1) 55
Crisp AJ See Barry MA; Lim KKT; Skingle SJ; Watts RA Datton S See Corbett M
Crort P, ScHotium J, Sirman A. Epidemiology of tender point counts in the Daty MJ See Foley-Nolan D
general population, (A1) 67 Dauziet M, AxForp JS. Serum and lymphocytic glycosyltransferase activity in
Crort P See also Ali-Gombe A; Marshall DAS rheumatic disease, (A1) 31
Crort PR, Ricsy AS, Pore DP, Boswett R. Repeatability of shoulder DarsysHirE PJ See Ewer AK
measurements in general practice, (A1) 72 DarLincton LG, Ramsey NW. Review of dietary therapy for rheumatoid
Cross_ey MJ See Dearman MS arthritis, 507
GENERAL INDEX
DarMAwAN J, MuiRDEN KD, VALKENBURG HA, WicLey RD. Epidemiology of glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and
rheumatoid arthritis in Indonesia, 537 mandible of nephrotic patients: a double-blind study on the high-dose
DasHwoop M See Vancheeswaran R long-term effects of prednisone versus deflazacort, (S2) 15
Data Sheet changes relevant to rheumatologist 1989-1992, (A1) 156 randomized, double-blind trial of deflazacort versus prednisone in juven-
DauGaarD H See Olgaard K ile chronic (or rheumatoid) arthritis: a relatively bone- sparing effect
Daunt SO’N See Watts RA of deflazacort, (S2) 31
Davip CS See Moder KG DEIGHTON C See Pile K
Davip J, Woops RJ, KENNEDY KM, BEHAN D, Potter E, VALE W, Lowry PJ. DEIGHTON CM. What is the future for the genetics of rheumatoid arthritis, (E)
Corticotrophin releasing factor binding protein in inflammatory arthritis, 857
(A2) 13 DEIGHTON CM, CavanaGu G, RicBy AS, Ltoyp HL, WaLkeER DJ. Both inherited
Davip J See also Hasson N; Loftus J; Rooney M HLA-haplotypes are important in the predisposition to rheumatoid
Davipson J See Hillarby MC arthritis, 893
Davies BH See Southcott AM DEIGHTON CM, McDonacu J, WALKER DJ. Rheumatoid arthritis nodules and
Davies EJ, HitLarsy MC, Cooper RG, Hay EM, Green JR, SHAH S, BERNSTEIN HLA-linkage, (A1) 112
RM, Hour PJL, GRENNAN DM. HLA associations with SLE, (A1) 116 DEIGHTON CM, Mastana S, PaptHA SS, WALKER DJ. Transferrin subtypes in
Davies EJ, HiLLarsy MC, Cooper RG, Hay EM, Green JR, SHAH S, BERNSTEIN rheumatoid arthritis sibships, (A2) 14
RM, Hott PJL, GRENNAN DM. HLA-DQ, DR and complement C4 varia- DEIGHTON CM, WILLIAMSON MMB, Dick WC. Rheumatoid arthritis patients
nts in systemic lupus erythematosus, 870 coping without drug therapy, 236
Davies EJ See also Hillarby MC DEIGHTON CM See also McDonagh CM
Davies J See Soriano E Demaziere A. Non-fatal bronchiolitis obliterans possibly associated with tio-
Davies JA. Abnormal fibrinolysis in chronic low back pain, (L) 853 pronin. A case report with long-term follow-up, (L) 172
Davies JA See also Zebouni LNP Demonstration of cytokeratin in endothelial cells of the synevial microvas-
Davies KA, Norswortny PJ, ToNoti M, Ross CN, TuRNER N, Loizou S, WAL- culature in situ and in vitro, 676
port MJ. Measurement of antibodies to Clq by ELISA using purified col- Dempsey O See Helliwell PS
lagen stalks from the molecule as the solid phase ligand, (A1) 7 Denervation effect on bradykinin responses in chronic arthritis, (A1) 37
Davies KA See also Beynon HLC; de Wit D DENMAN AM See Hermaszewski R
Davies U See Pile K Denton J See Dean G; Jones STM; Marshall DAS
Davies UM, Jones J, PREEcE MA, ANSELL BM, Woo P. Effect of growth hor- DERBYSHIRE SWG See Jones AKP
mone therapy on insulin-like growth factor (IGF) binding protein in juv- Dermatomyositis, adult, cyclosporin A, (L) 439
enile chronic arthritis, (A1) 135 Desnayes P See Chassagne Ph
Davies UM, Rooney M, Woo P. Serum insulin-like growth factor 1 and disease Detection
activity in growth retarded children with juvenile chronic arthritis, (A1) of anti-centromere autoantibodies using a newly developed enzyme
135 linked immunosorbent assay, (A2) 34
Davis M See Gates C; Hillarby MC; Morgan K of anti-RO(SSA) antibodies in autoimmune disease: comparison of five
Davis MJ See Hassell AB; Wilkinson SM methods, 449
Davis P. Mixed connective tissue disease, (L) 645 of antibodies to the 90KDa heat shock protein in patients with SLE and
Davis P See also Young A other autoimmune rheumatic diseases, (A2) 32
Davis S See Camilleri JP of keratan sulphate in osteoarthritic cartilage explants, (A2) 51 of myco-
Dawes PT See Borg AA; Close DR; Hassell A; Hassell AB; Mattey DL, Plant bacterial related antigen in serum immune complexes of rheumatoid
MJ; Sant SM; Wilkinson SM arthritis patients using antigen capture enzyme linked immunosor-
Dawson RA See Lindsey NJ bent assay (ELISA), (A1) 34
D’Cruz D, Cervera R, Otcay AypiIntuG A, AHMED T, Font J, HuGHEs GRV. Development
Systemic lupus erythematosus evolving into systemic vasculitis: a report of and assessment of a simple outcome score for routine use in rheumatoid
five cases, 154 arthritis, (A1) 121
D’Cruz D, DireskeneLi H, KHAMAsSHTA MA, HuGues GRV. Soluble T-cell of Hodgkin’s disease in the course of primary Sjégren’s syndrome (Erra-
receptors in Wegener’s granulomatosis: correlation with disease activity tum Vol 31:561), 157
and renal involvement, (A1) 25 Devey ME See Symmons D
D’Cruz D, Keser G, DiresKENELI H, KHaMAsHTA MA, Hucues GRV. Heat Devin J, GouGH A, Hutssoon A, Juss R, Emery P. Knee disease in 766
inactivation potentiates antiendothelial antibody binding in sera from early arthritis patients, relevance to outcome and pathogenesis, (A2) 5
patients with systemic vasculitis, (A1) 23 Devin J, Goucu A, Litey J, Eyre S, Emery P. High loss of bone mass docu-
D’Cruz D, KHamasuta M, HuGues GRV. Characterisation of antiendothelial mented in hands of patients with early rheumatoid arthritis, (A2) 4
cell antibody binding in lupus nephritis, (A1) 23 Devin J, KANE K, GorDon C, SHEPPARD MC, STEWARD PM, Emery P. Short
D’Cruz D See also Direskeneli H; McAlindon T; Wong WL synacthen test better predicts defective hypothalamic-pituitary-adrenal
De Bruyn M See Henrotin Y axis than the insulin tolerance test in patients receiving corticosteroids,
De Cos MA See Calvo-Alén J (A2) 41
De Haro L See Smith CR Devin J See also Byrne J; Gough A; Moots RJ
De Keyser F. Changes in antinuclear serology in patients with spondylarthro- DEVOGELAER JP, NAGANT De Deuxcualsnes C. Therapy and the 1990s, osteo-
pathy under sulphasalazine treatment, (L) 521 porosis, (S4) 48
De Kuoet ER See Griep EN Duar S, KLENERMAN L. Reflex sympathetic dystrophy (algodystrophy), (E) 2
De Leonarpis V See Pignone A DHILLON V, McCa.vum S, Witks D, Twomey B, LatcHMAN D, ISENBERG DA.
De Micuet E, HERNANZ A, Martin-Mo a E, Martinez M, Vazquez JJ, GUon Differential expression of heat shock proteins in rheumatic disease, 883
J, ARNALICH F. Inflammatory neuropeptides and cytokines in plasma and DHILLON V, McCa.vu §, Witks D, Twomey B, LatcHMAN DS, ISENBERG DA.
synovial fluid from patients with gout, (A1) 163 Heat shock proteins are differentially expressed in rheumatic disease,
De Micue E See also Hernanz A (Al) 32
De Roow DJ See Haagsma C; van den Hoogen FHJ DHILLON VB See Twomey BM
De Vries N. Genetic factors influencing the outcome of early arthritis — the role Di Battista E See Aicardi G
of sulphoxidation status, (L) 170 Di GiovinE FS See Wilson AG
De Vries N See also Wilson AG Diabetes mellitus, Charcot arthropathy as an unusual initial manifestation, (L)
De Wirt D, Mua R, Cowie MR, Mason JC, Davies KA. Vertebral osteomyel- 854
itis due to Staphylococcus epidermidis, 339 Diabetic hand, ABC - advanced glycosylation end products, browning and col-
Deacon A See Helliwell PS lagen, (E) 859
Dean G, Hoy_anp JA, DENTON J, DoNN RP, Freemont AJ. Mast cells in the Diagnosis of Poncet’s disease, 824
synovium and synovial fluid in osteoarthritis, 671 Diagnostic value of salivary gland scintigraphy in patients suspected of primary
DEARMAN MS, Crawrorpb A, CrossLey MJ. Role for IL-1 in the diminished Sjégren’s syndrome, 231
responsiveness of cartilage to IGF-1 in a murine model of arthritis, (A1) Dick WC See Deighton CM
119 Dickens AJG. Europe and the 1990s, the European Commission and health
Desy C See Henrotin Y care, (S4) 28
Desy-Dupont G See Henrotin Y Diemet LT See Garrett NE
Depe H. Tropical pyomyositis in a temperate climate, (L) 435 Dieppe P, CUSHNAGHAN J, JasAnt MK, McCrae F, Wart I. Two-year placebo-
Defining spinal mobility in ankylosing spondylitis as new metrology score, controlled trial of non-steroidal anti-inflammatory therapy in osteoar-
(A1) 65 thritis of the knee joint, 595
Deflazacort Diepre P See also Cushnaghan J; Doherty M; George E; Hayes A; Haynes J;
dose-dependent effects of deflazacort and prednisone on growth and Kassimos D; Lim KKT; McAlindon T; Poole AR; Rogers J; Shellis RP;
skeletal maturation, (S2) 39 Snow S; Swan AJ; Szbengi B; Veerapen K; Warnock MG
10 GENERAL INDEX
Dietary therapy for rheumatoid arthritis, 507, (L) 1030 DonneELLy S See also Wallace E
Differential effect of glucocorticoids on calcium absorption and bone mass, Dornan TL See Ray DW
(S2) 11 Dose-dependent effects of deflazacort and prednisone on growth and skeletal
Differential expression maturation, (S2) 39
of 92kDa gelatinase B (MMP-9) and stromelysin (MMP-3) by rheumatoid Double-blind controlled study of testosterone therapy in male rheumatoid
synovial cells in vitro and in vivo, (A1) 40 arthritis, (A1) 50
of heat shock proteins in rheumatic disease, 883 Double-blind controlled trial of intra-articular corticosteroids for chronic cer-
Differential therapeutic response in AIDS-associated polyarthritis, (L) 346 vical zygapophyseal joint pain, (A2) 53
Differentiating persistent from self-limiting symmetrical synovitis in an early Double-blind multi-centre placebo controlled study of sulphasalazine in 351
arthritis clinic, 97, (L) 764 patients with spondylarthropathy, (A1) 103
Digital blood flow response to environmental changes in Raynaud’s phenom- Double-blind placebo-controlled study of erythropoietin in anaemic patients
enon, (Al) 77 with rheumatoid arthritis, (A1) 102
Digital sympathectomy in the treatment of severe refractory Raynaud’s syn- Double-blind study of the effectiveness of low level laser treatment of rotator
drome, (A1) 74 cuff tendinitis, 740
Digital vasculopathy associated with hyperparathyroidism, (L) 86 Double-blind trial comparing subacromial methylprednisolone and lignocaine
Duxmans BAC See Eggelmeijer F; Janssen M; Landewé RBM in acute rotator cuff tendinitis, 743
Direct evidence for the presence of hydroxyl radical in rheumatoid synovial Doucapbos M, Tor.ey H. Efficacy of cyclosporin A in rheumatoid arthritis:
fluid, (A1) 158 worldwide experience, (S1) 57
DireskeNeLt H, D’Cruz D, KHamasuta MA, Hucues GRV. Autoantibodies Doucapos M See also Calin A
against endothelium, collagen and subendothelial matrix in systemic vas- Doucias-Jones AG See Camilleri JP
culitis, (A1) 22 Dow inc E See Chander C
DiRESKENELI H, D’Cruz D, KHamasuta MA, Hucues GRV. Soluble adhesion Downs syndrome associated arthropathy, (A1) 145
molecule detection in rheumatoid synovial fluid, (A1) 22 Doy.e DV, Perrett D, Foster OJF, ENsor M, Scotr DL. Long-term use o*
DtRESKENELI H See also D’Cruz D D-penicillamine for treating rheumatoid arthritis: is continuous therapy
Disability necessary, 614
and rheumatic disease: who sees the GP and who rarely sees anyone, (A1) Doy.e DV See also Comer M; Donnelly S; Johansen A; Masud T
151 DQA-DR haplotypes, unusual in rheumatoid vasculitis, 93
expectation and perception in patients with rheumatoid arthritis, (A1) 152 Drewes AM, ANDREASEN A, SCHRODER HD, Hoacsaa B, JENNUM P. Pathology
in persons aged 85 and over. A population survey, (A1) 126 of skeletal muscle in fibromyalgia: a histo-immuno-chemical and ultra-
Disabled patients, unmet needs of patients attending the rheumatology clinic, structural study, 479
(A2) 57 Drosos AA See Vlachoyiannopoulos PG
Disabled people, effect of medical training on attitudes, (A1) 151 Drover S See Hajeer AH
Disablement associated with rheumatic disorders in a British population: prob-
Drug responses, genetic basis - a rheumatological perspective, 181
lems with activities of daily living and level of support, 601 Drug toxicity, suspected cutaneous in rheumatoid arthritis — an evaluation, 798
Discrimination between controls, primary Raynaud’s phenomenon and secon- Du Bots RM See Southcott AM
dary Raynaud’s phenomenon in thermography at 30°C, (A1) 73
Dupuia J See Noble DP
Disease Dub tey Hart F. Rheumatic fever in the pre-war years in Great Britain, 419
activity in rheumatoid arthritis correlates with IL-6, (A1) 167
Dupb ey M See Yanni G
education video for children with arthritis, (A1) 133
Durr GW. Cytokines and anti-cytokines, (S1) 15
Drxey J, Morano EF, Dopps R, Batsa A, Pitsi_tipes AA, Epwarps JCW, Durr GW See also Blakemore AIF; McDowell TL; Wilson AG
Gou pine NJ. Localisation of annexins I, 11, 1V and V1 in the rheumatoid
Dumonpe DC See Brown KA
synovium, (A1) 38
Dunsar PR, Harrison A, Corkitt MM, Neate TJ. Immunoassay of platelet-
Drxe J See Young A derived growth factor in the plasma of patients with scleroderma, 966
Dixon JS See Astbury C
Dunnes CA, Moran C, THompson PW. Comparison of bone mineral density in
DNA strand breaks in the rheumatoid T ceh population, (A1) 29
Do bony swelling and crepitations precede radiographic evidence of knee rheumatoid arthritis patients taking corticosteroids orally, intramuscu-
osteoarthritis, (A2) 50 larly or not at all, (A2) 41
Do corticosteroids have any actions as second-line agents, (A1) 51 Durkin CJ See Chakravarty K
Do osteoarthritic knees with chronic effusions demonstrate arthrogenic inhibi- Dutch functional index for ankylosing spondylitis, (A1) 64
tion, (A2) 47
E-selectin levels in serum and synovial fluid from patients with psoriatic and
Do patients with rheumatological diseases consider alternative therapies, (A2) other inflammatory arthropathies, (A2) 26
ov Early effect of stopping 17{-estradiol administration on bone formation in
Dosss D See Wright D
Dopp E See Plant MJ Earlyo vrahreiuemcattoomiidse da rtrhartist, is( A1) 43
Dopps R See Dixey J
clinical patterns and outcome during first 3 years in 207 patients, (A1) 97
Dopps W. Injection therapy of superficial rheumatoid nodules, (L) 263
DDooeess htyhpe otphryersoeincdei smo f inpcsroeraiassei s thei nfplrueevnaclee nctehe opfr ecsheonntdartociaolnc inoof siisn,f la1m9m7a tory EARNiSnH AthWe fWooCt: Speeed oWbhayrtoeg raJp hic assessment, (A2) 4
Easte.t R See Peel NFA
polyarthritis? Results from the Norfolk Arthritis Register, (A1) 62
Does secondary Sjégren’s syndrome contribute to the observed increase in the Eastwoop B See Fisk JD; Hanly JG
airways obstruction in rheumatoid arthritis, (A1) 143 EBRINGER A, WILSON C, AHMADI K, WrIGGLESWorTH J, Tiwana H, BINDER A,
Donerty E, McKane R, Conroy R, Yanni G, MuLHeERIN D, BELL A, TAGGART Errecaie C, CUNNINGHAM P, Bansa_ S. Molecular similarity and immune
A. BRESNIHAN B. Health status of adults with chronic arthritis since child- response to a Proteus mirabilis membrane haemolysin antigenic determi-
hood: a collaborative study between the Republic of Ireland and Northern nant in rheumatoid arthritis which is homologous with the HLA-DRI1
Ireland, (A2) 59 DR4 susceptibility sequence, (A2) 10
Douerty M, Dieppe P, Wart I. Pyrophosphate arthropathy: a prospective Economou G See Jones PBB
Epmonps J See Calin A; Jaworski R
study, 189
Douerty M See also Hopkinson ND; Jones A; Jones AC; Ledingham J; Pat- Epmonps S See Sahinoglu T
trick M; Regan M; Samanta A Epmonps SE, Kaur H, Cuirico S, BLAKE DR, HALLIWELL B. Direct evidence
Douerty S See Ledingham J for the presence of hydroxyl radical in rheumatoid synovial fluid, (A1) 158
Dona.p F See Jones A Epwarps A See Kirwan J
Donn R, THomson W, Hout L, Powis SH, Outer W. Lack of association Epwarps J See Cambridge J
between TAP-2 gene polymorphisms and juvenile chronic arthritis, (A1) Epwarps JC See Fairburn K
109 Epwarps JCW See Dixey J; Henderson KJ; Noble DP; Pitsillides AA; Wilkin-
Donn R See also Thomson W son LS
Donn RP See Dean G Epwarps OM See Skingle SJ
Donne.ty S, Bourne JT, Levison DA, DoyLeE DV, HAMMonpb A. Amyloid Eeroia E See Peltonen R
arthritis associated with IgM kappa lymphoplasmacytoid lymphoma, 1004 Effect
Donne ty S, Doyte DV. Is bone density in ankylosing spondylitis affected by of an education programme on the perception of arthritis by spouse of
associated conditions or the patterns of joint involvement, (A1) 64 patients with rheumatoid arthritis, (A1) 153
Donne.ty S, Doyte DV. Is there a difference between male and female bone of corticosteroid therapy on bone mineral density in SLE patients, (A1) 55
density and vertebral fracture rates in ankylosing spondylitis, (A1) 131 of cyclosporin A on bone and cartilage, (S1) 42
Donne ty S, Levison DA, DoyLe DV. Systemic lupus erythematosus-like syn- of cytokines and growth factors on apoptotic polymorph (PMNL) phago-
drome with focal proliferative glomerulonephritis during p-penicillamine cytosis and clearance by normal blood monocyte derived macro-
therapy, 251 phages, (A1) 166